Amyloid- and tau-PET imaging in a familial prion kindred
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 17, 2017
- Accepted in final form October 5, 2018
- First Published December 3, 2018.
Author Disclosures
- David T. Jones, MD,
- Ryan A. Townley, MD,
- Jonathan Graff-Radford, MD,
- Hugo Botha, MB, ChB,
- David S. Knopman, MD,
- Ronald C. Petersen, MD, PhD,
- Clifford R. Jack Jr, MD,
- Val J. Lowe, MD and
- Bradley F. Boeve, MD
- David T. Jones, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryan A. Townley, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan Graff-Radford, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Institute of Aging K76 AG057015-01 year 2
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hugo Botha, MB, ChB,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH, R01 DC012519-06, co-investigator, 07/2018-06/2023
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David S. Knopman, MD,
Consultant Bluefield project (frontotemporal dementia) (ongoing); Lundbeck Pharmaceuticals (Sept 2013 to August 2017); DIAN study DSMB (Sept 2013 ongoing).
NONE
(1) Lectures, Behavioral Neurology Conference, Hyderabad, India April 2016
Omsbudsman Neurology, currently
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Tau Rx clinical trial funded by TAURX (site PI)ended 2017 (2) A4 clinical trial partially funded by Lilly (site PI) (3) Biogen Alzheimer Study (site PI)
NIH: R01-AG11378 ongoing, P50-AG 16574 (Mayo Alzheimer?s Disease Research Center) ongoing, U01 AG 06786 (Mayo Alzheimer Disease Patient Registry) ongoing. 1U01HL096917-01 ARIC Dementia Study. AG 037551 Chronic Kidney Disease and Cognitive functioning.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ronald C. Petersen, MD, PhD,
NONE
NONE
NONE
NONE
NONE
Mild Cognitive Impairment,Oxford University Press, 2003
NONE
(1) Roche Incorporated, (2) Merck, (3) Genentech, (4) Biogen, (5) GE Healthcare (presentation)
NONE
NONE
NONE
NONE
National Institute on Aging: U01-AG006786 (PI) (1986-present) P50-AG016574 (PI) (1990-present) U01-AG024904 (PI) (2004-present) U01 AG016976 (PI) (1989 ? present)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Clifford R. Jack Jr, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Eli Lilly - consultant with no financial compensation Roche - iDSMB with no financial compensation
NONE
NONE
National Institutes of Health: R01 AG011378, U01 AG024904, RO1 AG041851, R01 AG037551, R01 AG043392, U01 AG006786
NONE
The Alexander Family Professorship for Alzheimer's disease Research, Mayo Clinic
NONE
NONE
NONE
NONE
NONE
NONE
- Val J. Lowe, MD and
(1) Piramal Imaging (2) Merck Research, INC (3) Bayer Schering Pharma
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) GE Health Care (2) AVID Radiopharmaceuticals (3) Siemens Molecular Imaging
(1) NIA R01 DC010367-01, CoI, 12/01/09-11/30/14 (2) NIA P50 AG016574-12, Co-PI Project #1, 05/01/09- 04/30/14 (3) NIA R01 AG011378-16, CoI, 06/01/08-05/31/13 (4) NCI R01 R01CA 200551-1 , CoI, 02/01/16-11/30/19 (6) P50 CA102701-07, CoI, 09/01/08-08/31/13 (7) R01 CA125614-04 , CoI,09/26/06-07/31/11 (8) R21 CA123909-02, CoI, 07/01/07-08/01/12 (9) U01AG 06786-30, CoI, 07/01/07-06/30/19 (10) UM1CA 186686-2,CoI, 04/17/14-02/28/19 (11) R01 AG41851-4, CoI, 04/01/12-03/28/17 (12)P50 AG44170-4, CoI, 09/01/12-05/31/17 (13)R01 DC012519-1, CoI, 07/01/13-06/30/18 (14)R01CA 154348-4, CoI, 07/18/14-12/31/16 (15)R21AG 47984-1, PI, 09/01/15-05/31/17 (16)R01NS 89757-1, CoI, 09/15/15-08/31/20
NONE
(1) MN Partnership for Biotechnology and Medical Genomics (2) Elsie and Marvin Dekelboum Family Foundation (3) Liston Family Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Bradley F. Boeve, MD
Tau Consortium
NONE
NONE
NONE
NONE
Miller BL, Boeve BF (Eds). Behavioral Neurology of Dementia, Cambridge: Cambridge University Press, 2009, 2017.
NONE
NONE
NONE
NONE
NONE
Grant support as an investigator in clinical trials funded by GE Healthcare, 2012-2017; Axovant, 2016-2017; Biogen, 2018-present.
NIH: P50 AG016574 (2009-present), U01 AG006786 (2009- present), RO1 AG032306 (2010-present), RO1 AG041797 (2012- present), UO1 AG045390 (2014-present), U54 NS092089 (2014-present), U01 AG052943 (2016-present), R01 AG038791 (2017-present), UO1 NS100620 (2017-present), R44 AG050326 (2017-present), and R34 AG056639 (2018-present)
NONE
Mangurian Foundation, 2011-present Little Family Foundation, 2015-present
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (D.T.J., R.A.T., J.G.-R., H.B., D.S.K., R.C.P., B.F.B.) and Department of Radiology (D.T.J., C.R.J., V.J.L.), Mayo Clinic, Rochester, MN.
- Correspondence
Dr. Jones Jones.david{at}mayo.edu
Article usage
Cited By...
Letters: Rapid online correspondence
NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.ng.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.